Kymera Therapeutics CBO Elaine Caughey to depart April 10, 2023

Kymera Therapeutics, Inc.

Chief Business Officer Elaine Caughey departing for personal family reasons.
Departure effective as of April 10, 2023.
No replacement or interim appointment announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Elaine Caughey

Chief Business Officer

KYMR · Kymera Therapeutics, Inc.

Effective: 2023-04-10
Filed: February 27, 2023, 6:59 PM ET

Elaine Caughey, its Chief Business Officer, will be departing the Company for personal family reasons effective as of April 10, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Elaine Caughey departed as Chief Business Officer at Kymera Therapeutics, Inc..

Action: departing
Role: Chief Business Officer

Exact text from the filing

Elaine Caughey, its Chief Business Officer, will be departing the Company for personal family reasons effective as of April 10, 2023.

View on SEC.gov

Kymera Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-051009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.